Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores
NCT ID: NCT06293755
Last Updated: 2024-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE3
16 participants
INTERVENTIONAL
2024-02-28
2024-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Efficacy and Safety of Microneedling Combined With Botulinum Toxin-A Versus Meso-Botox Injection in the Treatment of Atrophic Acne Scars: A Split-face Comparative Study
NCT06544993
Fractional Co2 Laser Versus Microbotox Injection in the Treatment of Wide Facial Pores: A Split Face Comparative Study
NCT05923996
Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions
NCT05097157
Evaluation of Skin Quality Improvement
NCT03097835
A Pilot Study Testing the Efficacy of a Needling Device for the Treatment of Acne Scars
NCT00974870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Microneedle patch with Botulinum toxin
Participants recieve microneedle path with 20 units Botulinum toxin at nose and cheek one side.
Microneedle patch
with 20 units botulinum toxin
Intradermal Botulinum toxin injection
Participants recieve intradermal 20 units Botulinum toxin injection at nose and cheek in other side.
Intradermal injection
with 20 units botulinum toxin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microneedle patch
with 20 units botulinum toxin
Intradermal injection
with 20 units botulinum toxin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have pore size 0.3-0.6 mm
* Have pore parameter in each other side of faces not different more than 5%
Exclusion Criteria
* Pregnancy or breast feeding
* History of allergy : Botulinum toxin, topical anesthesia
* History of keloid or hypertrophic scar
* History of coagulation or receiving medication that causes coagulation disorder
* Using drugs that have interaction with Botulinum toxin
* Using topical medication that improves enlarged pores in 1 month
* Taking medication that improves enlarged pores in 1 month
* Receiving the laser/treatment/chemical peeling in 6 months
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dhurakij Pundit University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chotip Jitudomtham
Chotip Jitudomtham
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chotip Jitudomtham, MD
Role: PRINCIPAL_INVESTIGATOR
Dhurakij Pundit University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dhurakij Pundit University
Lak Si, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Salem RM, Salah SAE, Ibrahim SE. Microbotox injection versus its topical application following microneedling in the treatment of wide facial pores: A split face comparative study. J Cosmet Dermatol. 2023 Apr;22(4):1249-1255. doi: 10.1111/jocd.15590. Epub 2023 Jan 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COA022/66
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.